American Biotech company, Moderna, has suspended its construction of a vaccine-manufacturing plant in Kenya after registering a US$ 1 billion loss prompted by less demand for COVID-19 vaccines since 2022.  … Continue reading Moderna Halts Plans for Kenya Vaccine Plant After US$1 bn Loss